Boronic acid-containing aminopyridine- and aminopyrimidinecarboxamide CXCR1/2 antagonists: Optimization of aqueous solubility and oral bioavailability-Reference-Cited by-同舟云学术

Boronic acid-containing aminopyridine- and aminopyrimidinecarboxamide CXCR1/2 antagonists: Optimization of aqueous solubility and oral bioavailability

Published:2015-09 Issue:18 Volume:25 Page:3793-3797
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Schuler Aaron D.,Engles Courtney A.,Maeda Dean Y.,Quinn Mark T.,Kirpotina Liliya N.,Wicomb Winston N.,Mason S. Nicholas,Auten Richard L.,Zebala John A.

Funder

National Institutes of Health

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference36 articles.

1. Small Molecule Antagonists of the CXCR2 and CXCR1 Chemokine Receptors as Therapeutic Agents for the Treatment of Inflammatory Diseases

2. CXCR2 Receptor Antagonists: A Medicinal Chemistry Perspective

3. Blockade of CXCR2 signalling: A potential therapeutic target for preventing neutrophil-mediated inflammatory diseases

4. Chemokines in pathology and medicine

5. Severe asthma: future treatments

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Myeloid-Derived Suppressor Cell Trafficking as a Novel Immunotherapeutic Approach in Microsatellite Stable Colorectal Cancer;Cancers;2023-11-20

2. Therapeutic inhibition of CXCR1/2: where do we stand?;Internal and Emergency Medicine;2023-05-30

3. The Boron Advantage: The Evolution and Diversification of Boron’s Applications in Medicinal Chemistry;Pharmaceuticals;2022-02-22

4. Targeting chemokine receptors from the inside-out: discovery and development of small-molecule intracellular antagonists;Chemical Communications;2022

5. Discovery of 1,5-Dihydro-4H-imidazol-4-one Derivatives as Potent, Selective Antagonists of CXC Chemokine Receptor 2;ACS Medicinal Chemistry Letters;2021-04-08